Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2015

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • dingleberryD Offline
    dingleberryD Offline
    dingleberry
    wrote on sidst redigeret af
    #475

    Dara er tema i 24 abstracts - elotuzumab er med i 13...

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #476

      Mono: 31 % ORR er da kun blevet bedre?

      1 Reply Last reply
      0
      • FantomasF Offline
        FantomasF Offline
        Fantomas
        wrote on sidst redigeret af
        #477

        Conclusions: Robust T cell increases, increased CD8+: CD4+ ratios, increased antiviral responses, and increased T cell clonality were all observed after DARA treatment in a heavily pretreated, relapsed, and refractory patient population not expected to have strong immune responses. Improved clinical responses were associated with changes in these parameters. In addition, a sub-population of regulatory T cells expressing high CD38 levels was determined to be extremely immune suppressive and sen

        1 Reply Last reply
        0
        • FantomasF Offline
          FantomasF Offline
          Fantomas
          wrote on sidst redigeret af
          #478

          sensitive to DARA treatment. These data suggest a previously unknown immune modulatory role of DARA that may contribute to its efficacy, and a potential role for CD38 immune targeted therapies. We postulate that there are several distinct and complementary mechanisms that contribute to DARA’s efficacy including increased antigen presentation through phagocytosis, targeting of immune suppressive Tregs, and increased adaptive immune responses.

          1 Reply Last reply
          0
          • FantomasF Offline
            FantomasF Offline
            Fantomas
            wrote on sidst redigeret af
            #479

            https://ash.confex.com/ash/2015/webprogram/Paper79122.html taget herfra selvfølgelig.

            1 Reply Last reply
            0
            • J Offline
              J Offline
              JKY_VH
              wrote on sidst redigeret af
              #480

              takker, spændende

              1 Reply Last reply
              0
              • L Offline
                L Offline
                LithiumJay
                wrote on sidst redigeret af
                #481

                Conclusions: The addition of DARA to POM-D was well tolerated and did not result in additional toxicities with the exception of DARA-related infusion
                reactions. Deep and durable responses were observed quickly, along with a high response rate. Study enrollment is ongoing and data will be updated at the meeting.

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  LithiumJay
                  wrote on sidst redigeret af
                  #482

                  ^ det tegner godt for godkendelsen

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #483

                    Dara+len-dex har 88% ORR. Elo+len-dex Har 79% ORR

                    1 Reply Last reply
                    0
                    • H Offline
                      H Offline
                      havana
                      wrote on sidst redigeret af
                      #484

                      Har FDA allerede haft adgang til disse data fra abstracts, eller er det først nu?

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #485

                        Det må vi formode med den rullende ansøgning.

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #486

                          3 mundtlige præsentationer. Især pomalidomide bliver interessant.

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            stckchild
                            wrote on sidst redigeret af
                            #487

                            Vi vinker desværre farvel til 700 lige om lidt, er spændt på hvordan vi kommer over for at blive der, men vi skal nok desværre hen til godkendelse før vi en gang for alle ryger forbi,

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              stckchild
                              wrote on sidst redigeret af
                              #488

                              Eller satser vi på et gab luk 🐵

                              1 Reply Last reply
                              0
                              • S Offline
                                S Offline
                                stckchild
                                wrote on sidst redigeret af
                                #489

                                Abstracts dårligere end ventet ?

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #490

                                  Data er så gode at vi sover trygt om natten. Interessant hvad de mener den immunmodulerende effekt kan bruges til.

                                  1 Reply Last reply
                                  0
                                  • M Offline
                                    M Offline
                                    Mcjean
                                    wrote on sidst redigeret af
                                    #491

                                    Der bliver solgt på facts, hvilket er fornuftigt. Facts er at der intet nyt er i abstracts som ikke var forventet.

                                    1 Reply Last reply
                                    0
                                    • dingleberryD Offline
                                      dingleberryD Offline
                                      dingleberry
                                      wrote on sidst redigeret af
                                      #492

                                      facts er at US tordner ned. Derfor skal vi også ned

                                      1 Reply Last reply
                                      0
                                      • Smadsen128S Offline
                                        Smadsen128S Offline
                                        Smadsen128
                                        wrote on sidst redigeret af
                                        #493

                                        Alt kan ske i tossetimen

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #494

                                          Just a moment...

                                          favicon

                                          (www.proinvestor.com)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger